Ginkgo leaves with improved medicinal quality and processing method thereof

The flavonoid metabolism-related enzymes in ginkgo leaves are activated by low-temperature plasma treatment, which significantly increases the total flavonol glycoside content of ginkgo leaves and reduces the ginkgo acid content, solving the problems of processing complexity and component loss in the prior art. , achieving a significant improvement in the medicinal quality of ginkgo leaves.

CN118903225APending Publication Date: 2024-11-08JIANGSU UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410957074.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-17
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing ginkgo leaf processing methods are complex, costly and cannot effectively increase the total flavonol glycoside content. At the same time, there are problems such as loss of flavonol glycoside and unstable ginkgo acid content, making it difficult to significantly improve the quality of medicine.

Method used

Ginkgo leaves are placed in a low-temperature plasma for treatment, and the plasma active ions and high-energy particles act to activate the metabolism-related enzymes of flavonoid compounds in the leaves, promote the biosynthesis of flavonol glycosides, and obtain the medicine through dark room incubation and drying. Use quality-improved ginkgo leaves.

Benefits of technology

It significantly increases the total flavonol content in ginkgo leaves, reduces the content of ginkgo acid, improves the improvement rate of medicinal quality, avoids the process complexity and loss of beneficial ingredients in traditional methods, and has higher safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004949165910000031
    Figure BDA0004949165910000031
  • Figure BDA0004949165910000032
    Figure BDA0004949165910000032
Patent Text Reader

Abstract

The invention discloses ginkgo leaves with improved medicinal quality and a processing method thereof, and belongs to the technical field of plant traditional Chinese medicinal material processing. The method comprises the following steps: firstly, treating ginkgo leaves by using a low-temperature plasma method, and then incubating in a darkroom to promote the biosynthesis of flavonoid compounds and reduce the content of a toxic component ginkgolic acid at the same time. And finally, performing low-temperature drying and the like to obtain the ginkgo leaves with improved medicinal quality. The ginkgo leaves are treated by adopting a low-temperature plasma method, the ginkgo leaves are subjected to surface treatment by utilizing active ions, high-energy particles and etching action of plasma, flavonoid compound metabolism-related enzymes and biosynthesis pathways in the leaves are activated, the content of total flavonol glycosides is remarkably increased, and meanwhile the content of ginkgolic acid is reduced; the medicinal quality of the ginkgo leaves is obviously improved. In addition, the problems of complex process, solvent residue, serious loss of beneficial components, poor retention and the like caused by traditional ginkgolic acid content reduction are avoided, and related potential safety hazards are effectively solved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to ginkgo leaves with improved medicinal quality and a processing method thereof, belonging to the technical field of plant-based traditional Chinese medicine processing. Technical Background

[0002] Ginkgo biloba has high medicinal value, is neutral in nature, and tastes sweet, bitter, and astringent. It has the effects of promoting blood circulation and removing blood stasis, removing turbidity and reducing lipids. Studies have shown that ginkgo biloba has multiple pharmacological activities such as anti-inflammatory, anti-tumor, memory improvement, blood sugar reduction, and treatment of cardiovascular and cerebrovascular diseases. Ginkgo biloba medicines account for more than 95% of the herbal medicines used in the clinical treatment and prevention of cardiovascular and cerebrovascular diseases in the world. However, because the chemical composition of ginkgo biloba is complex, it is the richest compound content among plants known to mankind, and it is estimated to contain more than 200 compounds, so there is an urgent need for a way to improve the medicinal quality of ginkgo biloba.

[0003] Flavonol glycosides and ginkgolic acid are the most important active ingredients in ginkgo leaves. The former has multiple pharmacological effects such as anti-inflammatory, antioxidant, and immunity enhancement, and is the most important quality component of ginkgo leaves. According to the 2020 edition of the Chinese Pharmacopoeia, the total flavonol glycoside content in ginkgo leaves must not be less than 0.4%; while the latter is toxic, and the main toxicity includes sensitization and mutagenicity. In the relevant standard requirements, the ginkgolic acid content must be less than 5ppm. Therefore, increasing the total flavonol glycoside content in ginkgo leaves and removing ginkgolic acid are important ways to improve the medicinal quality of ginkgo leaves.

[0004] At present, in the processing of ginkgo leaves, the methods for removing ginkgolic acid include: compatibility method, organic solvent extraction method, fermentation method, supercritical CO2 method, macroporous resin method, etc. These methods not only have complex production processes, high production costs, and long production cycles, but also have disadvantages such as unstable deacidification quality and large loss of flavonol glycosides.

[0005] Therefore, studying a ginkgo leaf processing method that can significantly increase the content of total flavonol glycosides while reducing the content of the toxic component ginkgolic acid is of great significance to improving the medicinal value and economic value of ginkgo leaves. Summary of the invention

[0006] The present invention aims at some deficiencies of the prior art and provides a ginkgo leaf with improved medicinal quality and a processing method thereof. The present invention firstly processes the ginkgo leaf in a low-temperature plasma, and uses the active ions, high-energy particles and etching effect of the plasma to perform surface treatment on the ginkgo leaf, thereby activating enzymes and biosynthetic pathways related to flavonoid compound metabolism in the leaf and promoting the biosynthesis of flavonol glycosides. This treatment method can not only effectively reduce the content of ginkgolic acid, but also significantly increase the content of total flavonol glycosides, which are beneficial ingredients.

[0007] In order to achieve the above technical purpose, the technical solution adopted by the present invention is as follows:

[0008] The present invention first provides a method for processing ginkgo leaves, the processing method comprising the following steps:

[0009] (1) Placing the ginkgo leaves in a low-temperature plasma device for treatment;

[0010] (2) incubating the ginkgo leaves treated in step (1) in a dark room;

[0011] (3) Drying the ginkgo leaves incubated in the dark room in step (2), and cooling them to obtain ginkgo leaves with improved medicinal quality.

[0012] Among them, the medicinal quality improvement includes increasing the content of flavonol glycosides and reducing the content of ginkgolic acid in ginkgo leaves;

[0013] The ginkgo leaves in step (1) are green, spot-free, 5-7 month old ginkgo leaves;

[0014] The parameters of the low-temperature plasma equipment are set as follows: processing voltage 30-70V, processing frequency 100-1000Hz, processing time 5-120s, plate spacing 5-20mm, and duty cycle 30%-90%.

[0015] Preferably, the parameters of the low-temperature plasma equipment are set as follows: processing voltage 50-70V, processing frequency 600-800Hz, processing time 30-60s, plate spacing 10-15mm, and duty cycle 50%-80%.

[0016] The treatment method is of dielectric barrier discharge type.

[0017] The incubation conditions in step (2) are: incubation temperature of 15-20° C., relative air humidity of 80-90% RH, and incubation time of 12-24 h.

[0018] The drying temperature in step (3) is 45-70° C., preferably, 50-60° C., and the drying is stopped when the moisture content of the ginkgo leaves is below 20%.

[0019] The present invention also provides a ginkgo leaf with improved medicinal quality obtained by the processing method, wherein the improved medicinal quality of the ginkgo leaf includes increasing the content of flavonol glycosides and reducing the content of ginkgolic acid in the ginkgo leaf.

[0020] Compared with the prior art, the present invention has the following beneficial effects:

[0021] (1) The present invention uses a low-temperature plasma method to treat ginkgo leaves, thereby activating enzymes related to the metabolism of flavonoid compounds and biosynthetic pathways in the leaves. Therefore, compared with untreated ginkgo leaves, the content of total flavonol glycosides in the ginkgo leaves treated by the low-temperature plasma method of the present invention is increased, and the content of the toxic component ginkgolic acid is reduced. At the same time, the quality improvement rate of ginkgo leaves can reach up to 93.80%, indicating that treating ginkgo leaves with the method of the present invention can significantly improve the medicinal quality of ginkgo leaves.

[0022] (2) The present invention avoids the problems of complex process, solvent residue, serious loss and poor retention of beneficial ingredients such as flavonol glycosides caused by the traditional method of reducing the content of ginkgolic acid. At the same time, the processing method described in the present invention does not involve dangerous reagents and avoids safety hazards. DETAILED DESCRIPTION

[0023] In order to enable those skilled in the art to better understand the technical solution of the present invention, a detailed description is given below in conjunction with specific embodiments, but the following embodiments do not limit the protection scope of the present invention.

[0024] In the embodiments of the present invention, those that are not described in detail are all completed by conventional experimental methods. Those processes involved in the embodiments that are not described in detail are all understandable and easily implementable by those skilled in the art based on the product instructions or basic knowledge in the field, and therefore are not described in detail.

[0025] In order to comprehensively evaluate the changes in the beneficial medicinal components (total flavonol glycosides) and harmful components (total ginkgolic acid) before and after treatment with Ginkgo biloba leaves, the concept of "Ginkgo Leaf Benefit-Risk Ratio (BRR)" is introduced, that is, the content of beneficial medicinal components of Ginkgo biloba leaves / the content of toxic components. Since flavonol glycosides are the main beneficial medicinal components of Ginkgo biloba leaves and ginkgolic acid is the main toxic component, the "Ginkgo Leaf Benefit-Risk Ratio" can be narrowly approximated to be the total flavonol glycoside content / total ginkgolic acid content, see formula (1).

[0026]

[0027] Based on the concept of Ginkgo biloba benefit-risk ratio (BRR), the improvement ratio of medicinal quality of Ginkgo biloba after low-temperature plasma treatment can be calculated by formula (2):

[0028]

[0029] The improvement ratio of medicinal quality of ginkgo leaves is positive, indicating that low-temperature plasma has a positive improvement effect on the quality of ginkgo leaves; the larger the value, the better the improvement effect of medicinal quality of ginkgo leaves, that is, the improvement of medicinal quality includes an increase in the content of flavonol glycosides and a decrease in the content of ginkgolic acid in ginkgo leaves.

[0030] The ginkgo leaves used in the following examples were all collected from the campus of Jiangsu University. They were green, spot-free, 5-7 month old (i.e., picked in May-July), and the ginkgo leaf plasma treatment equipment used dielectric barrier discharge low-temperature plasma. The contents of total flavonol glycosides and total ginkgolic acid in the following examples were measured by liquid chromatography. The following examples are only used to illustrate the processing method of improving the medicinal quality of ginkgo leaves in detail but not to limit the present invention.

[0031] Embodiment 1:

[0032] The processing method for improving the quality of ginkgo leaves is as follows:

[0033] ① Pick fresh green ginkgo leaves without disease spots on May 10th;

[0034] ② Place the ginkgo leaves in a low-temperature plasma equipment (purchased from Nanjing Suman Plasma Technology Co., Ltd., CTP-2000KP) reactor for treatment, where the treatment voltage is 50V, the treatment frequency is 600Hz, the treatment time is 30s, the plate spacing is 10mm, and the treatment duty cycle is 70%;

[0035] ③ Place the treated ginkgo leaves in a constant temperature box for dark room incubation, where the incubation temperature is 20°C, the relative humidity is 80%RH, and the incubation time is 24h;

[0036] ④ Place the incubated ginkgo leaves in a hot air drying oven for drying at a temperature of 60°C. Stop drying when the moisture content of the ginkgo leaves is below 20%;

[0037] ⑤ The ginkgo leaves are cooled to room temperature to obtain ginkgo leaves with improved medicinal quality.

[0038] The total flavonol glycoside content of the ginkgo leaves with improved medicinal quality obtained by this process is about 14.95 mg / g (according to the 2020 edition of the "Chinese Pharmacopoeia", the total flavonol glycoside content of ginkgo leaves is not less than 4 mg / g), which is 74.88% higher than that of untreated ginkgo leaves; the total ginkgolic acid content is about 7.47 mg / g, which is 9.77% lower than that of untreated ginkgo leaves; the benefit-risk ratio (BRR) of ginkgo leaves with improved medicinal quality is 1.90, and the quality improvement rate reaches 93.80%.

[0039] Embodiment 2:

[0040] The processing method for improving the quality of ginkgo leaves is as follows:

[0041] ① Pick fresh green ginkgo leaves without disease spots on June 5th;

[0042] ② Place the ginkgo leaves in a low-temperature plasma equipment reactor for treatment, where the treatment voltage is 30V, the treatment frequency is 600Hz, the treatment time is 30s, the plate spacing is 10mm, and the treatment duty cycle is 70%;

[0043] ③ Place the treated ginkgo leaves in a constant temperature box for dark room incubation, where the incubation temperature is 15°C, the relative humidity is 60%RH, and the incubation time is 6h;

[0044] ④ Place the incubated ginkgo leaves in a hot air drying oven for drying at a temperature of 50°C. Stop drying when the moisture content of the ginkgo leaves is below 20% on a wet basis.

[0045] ⑤ The ginkgo leaves are cooled to room temperature to obtain ginkgo leaves with improved medicinal quality.

[0046] The total flavonol glycoside content of the ginkgo leaves with improved medicinal quality obtained by this process is about 10.91 mg / g (according to the 2020 edition of the "Chinese Pharmacopoeia", the total flavonol glycoside content of ginkgo leaves is not less than 4 mg / g), which is 21.78% higher than the total flavonol glycoside content of untreated ginkgo leaves; the total ginkgolic acid content is about 6.61 mg / g, which is 10.28% lower than the total ginkgolic acid content of untreated ginkgo leaves; the benefit-risk ratio (BRR) of ginkgo leaves with improved medicinal quality is 1.65, and the quality improvement rate reaches 35.73%.

[0047] Embodiment 3:

[0048] The processing method for improving the quality of ginkgo leaves is as follows:

[0049] ① Pick fresh ginkgo leaves without disease spots on June 11;

[0050] ② Place the ginkgo leaves in a low-temperature plasma equipment reactor for treatment, where the treatment voltage is 40V, the treatment frequency is 1000Hz, the treatment time is 120s, the plate spacing is 15mm, and the treatment duty cycle is 50%;

[0051] ③ Place the treated ginkgo leaves in a constant temperature box for dark room incubation, where the incubation temperature is 25°C, the relative humidity of the air is 80%RH, and the incubation time is 12 hours to obtain the improved ginkgo leaves;

[0052] ④ Place the incubated ginkgo leaves in a hot air drying oven for drying at a temperature of 70°C. Stop drying when the moisture content of the ginkgo leaves is below 20%;

[0053] ⑤ The ginkgo leaves are cooled to room temperature to obtain ginkgo leaves with improved medicinal quality.

[0054] The total flavonol glycoside content of the ginkgo leaves with improved medicinal quality obtained by this process is about 11.61 mg / g, which is 13.60% higher than that of the untreated ginkgo leaves; the total ginkgolic acid content is about 6.97 mg / g, which is 19.26% lower than that of the untreated ginkgo leaves; the benefit-risk ratio of the ginkgo leaves with improved medicinal quality is 1.67, and the quality improvement rate reaches 40.69%.

[0055] Embodiment 4:

[0056] The processing method for improving the quality of ginkgo leaves is as follows:

[0057] ① Pick fresh ginkgo leaves without disease spots on July 10th;

[0058] ② Place the ginkgo leaves in a low-temperature plasma equipment reactor for treatment, where the treatment voltage is 70V, the treatment frequency is 100Hz, the treatment time is 5s, the plate spacing is 5mm, and the treatment duty cycle is 30%;

[0059] ③ Place the treated ginkgo leaves in a constant temperature box for dark room incubation, where the incubation temperature is 30°C, the relative humidity of the air is 90%RH, and the incubation time is 12 hours to obtain the improved ginkgo leaves;

[0060] ④ Place the incubated ginkgo leaves in a hot air drying oven for drying at a temperature of 60°C. Stop drying when the moisture content of the ginkgo leaves is below 20%;

[0061] ⑤ The ginkgo leaves are cooled to room temperature to obtain ginkgo leaves with improved medicinal quality.

[0062] The total flavonol glycoside content of the ginkgo leaves with improved medicinal quality obtained by this process is about 10.90 mg / g, which is 21.78% higher than that of the untreated ginkgo leaves; the total ginkgolic acid content is about 6.60 mg / g, which is 10.28% lower than that of the untreated ginkgo leaves; the benefit-risk ratio of the ginkgo leaves with improved medicinal quality is 1.65, and the quality improvement rate reaches 35.73%.

[0063] Embodiment 5:

[0064] The processing method for improving the quality of ginkgo leaves is as follows:

[0065] ① Pick fresh ginkgo leaves without disease spots on May 4th;

[0066] ② Place the ginkgo leaves in a low-temperature plasma equipment reactor for treatment, where the treatment voltage is 50V, the treatment frequency is 800Hz, the treatment time is 60s, the plate spacing is 20mm, and the treatment duty cycle is 90%;

[0067] ③ Place the treated ginkgo leaves in a constant temperature box for dark room incubation, where the incubation temperature is 20°C, the relative humidity of the air is 90%RH, and the incubation time is 36 hours to obtain the improved ginkgo leaves;

[0068] ④ Place the incubated ginkgo leaves in a hot air drying oven for drying at a temperature of 45°C. Stop drying when the moisture content of the ginkgo leaves is below 20%;

[0069] ⑤ The ginkgo leaves are cooled to room temperature to obtain ginkgo leaves with improved medicinal quality.

[0070] The total flavonol glycoside content of the ginkgo leaves with improved medicinal quality obtained by this process is about 12.34 mg / g, which is 46.71% higher than that of the untreated ginkgo leaves; the total ginkgolic acid content is about 6.99 mg / g, which is 0.85% lower than that of the untreated ginkgo leaves; the benefit-risk ratio of the ginkgo leaves with improved medicinal quality is 1.76, and the quality improvement rate reaches 48.00%.

[0071] Embodiment 6:

[0072] The processing method for improving the quality of ginkgo leaves is as follows:

[0073] ① Pick fresh ginkgo leaves without disease spots on May 20th;

[0074] ② Place the ginkgo leaves in a low-temperature plasma equipment reactor for treatment, where the treatment voltage is 40V, the treatment frequency is 600Hz, the treatment time is 30s, the plate spacing is 15mm, and the treatment duty cycle is 80%;

[0075] ③ Place the treated ginkgo leaves in a constant temperature box for dark room incubation, where the incubation temperature is 20°C and the relative humidity of the air is 90%RH. After the incubation time is 24 hours, the improved ginkgo leaves are obtained;

[0076] ④ Place the incubated ginkgo leaves in a hot air drying oven for drying at a temperature of 60°C. Stop drying when the moisture content of the ginkgo leaves is below 20%;

[0077] ⑤ The ginkgo leaves are cooled to room temperature to obtain ginkgo leaves with improved medicinal quality.

[0078] The total flavonol glycoside content of the ginkgo leaves with improved medicinal quality obtained by this process is about 12.10 mg / g, which is 35.12% higher than that of the untreated ginkgo leaves; the total ginkgolic acid content is about 5.78 mg / g, which is 21.45% lower than that of the untreated ginkgo leaves; the benefit-risk ratio of the ginkgo leaves with improved medicinal quality is 2.09, and the quality improvement rate reaches 72.01%.

[0079] The above embodiments are only used to illustrate the present invention and are not intended to limit the technical solutions described in the present invention; therefore, although the present invention has been described in detail in this specification with reference to the above embodiments, it should be understood by those skilled in the art that the present invention may still be modified or replaced by equivalents; and all technical solutions and improvements thereof that do not depart from the spirit and scope of the present invention should be included in the scope of the claims of the present invention.

Claims

1. A method for processing ginkgo leaves with improved medicinal quality, characterized in that: The processing method comprises the following steps: (1) Placing the ginkgo leaves in a low-temperature plasma device for treatment; (2) incubating the ginkgo leaves treated in step (1) in a dark room; (3) Drying the ginkgo leaves incubated in the dark room in step (2), and cooling them to obtain ginkgo leaves with improved medicinal quality.

2. The method for processing ginkgo leaves with improved medicinal quality according to claim 1, characterized in that: The improvement of medicinal quality includes increasing the content of flavonol glycosides and reducing the content of ginkgolic acid in ginkgo leaves.

3. The method for processing ginkgo leaves with improved medicinal quality according to claim 1, characterized in that: The ginkgo leaves in step (1) are green, spot-free, 5-7 month old ginkgo leaves.

4. The method for processing ginkgo leaves with improved medicinal quality according to claim 1, characterized in that: The parameters of the low-temperature plasma equipment in step (1) are set as follows: processing voltage 30-70V, processing frequency 100-1000Hz, processing time 5-120s, plate spacing 5-20mm, and duty cycle 30%-90%.

5. The method for processing ginkgo leaves with improved medicinal quality according to claim 4, characterized in that: The parameters of the low-temperature plasma equipment are set as follows: processing voltage 50-70V, processing frequency 600-800Hz, processing time 30-60s, plate spacing 10-15mm, and duty cycle 50%-80%.

6. The method for processing ginkgo leaves with improved medicinal quality according to claim 1, characterized in that: The low-temperature plasma equipment in step (1) is of dielectric barrier discharge type.

7. The method for processing ginkgo leaves with improved medicinal quality according to claim 1, characterized in that: The incubation conditions in step (2) are: incubation temperature of 15-30° C., relative air humidity of 60-90% RH, and incubation time of 6-36 hours.

8. The method for processing ginkgo leaves with improved medicinal quality according to claim 7, characterized in that: The incubation conditions are as follows: incubation temperature is 15-20° C., relative air humidity is 80-90% RH, and incubation time is 12-24 hours.

9. The method for processing ginkgo leaves with improved medicinal quality according to claim 1, characterized in that: The drying temperature in step (3) is 45-70°C, preferably, the drying temperature is 50-60°C.

10. The ginkgo leaves with improved medicinal quality obtained by the processing method of the ginkgo leaves with improved medicinal quality according to any one of claims 1 to 9, wherein the improved medicinal quality of the ginkgo leaves includes an increased content of flavonol glycosides and a reduced content of ginkgolic acid in the ginkgo leaves.

Citation Information

Patent Citations

  • Process for removing ginkgolic acids and enriching ginkgo flavonol glycosides and ginkgolides

    CN108659069A

  • Chinese herbal medicine composition as well as preparation and application thereof

    CN114010703A